
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
PAREXEL International Corporation and Meiji Pharmaceutical University announced a new Joint Program for Clinical Research and Clinical Trial Management for undergraduate students. The program offers students an accredited, four-week course designed to prepare them for careers in the biopharmaceutical industry which will be provided through PAREXEL’s clinical research expertise and MPU’s industry training experience.
Read the full release






